Environ 800 000 Canadiens ont une maladie artérielle périphérique (MAP), une cause majeure d’amputation. Pourtant, le public et les cliniciens connaissent très peu cette maladie. Le présent article traite de la campagne de sensibilisation Si vous pensez que c’est juste un mal de jambe… détrompez-vous que l’Association canadienne du soin des plaies a lancée pour contrer cette tendance. Il porte également sur les facteurs de risque et le dépistage de la MAP, son lien avec le diabète, son traitement et ses soins, ses innovations en matière de soins de la MAP et la nécessité de faire preuve de leadership sur le plan des politiques.
Get full access to this article
View all access options for this article.
References
1.
LovellMHarrisKForbesT. Peripheral arterial disease: lack of awareness in Canada. Can J Cardiol. 2009;25(1):39–45.
2.
2011 Writing Group Members; 2005 Writing Committee Members; ACCF/AHA Task Force Members. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;124(18):2020–45. doi:10.1161/CIR.0b013e31822e80c3.
HaighKJBingleyJGolledgeJWalkerPJ. Barriers to screening and diagnosis of peripheral artery disease by general practitioners. Vasc Med. 2013;18(6):325–30.
5.
MargolisJBarronJJGrochulskiWD. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm. 2005;11(9):727–34.
6.
MigLiaccio-WalleKCaroJJIshakKJO’BrienJA. Costs and medical care consequences associated with diagnosis of peripheral arterial disease. Pharmacoeconomics. 2005;23(7): 733–42.
7.
Qualité des services de santé Ontario. Hyperbaric oxygen therapy for nonhealing ulcers in diabetes mellitus: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(11):1–28.
8.
BrownriggJRWSchaperNCHinchliffeRJ. Diagnosis and assessment of peripheral arterial disease in the diabetic foot. Diabet Med. 2015;32(6):738–47. doi:10.1111/dme.12749
KuhnkeJLBotrosMElliottJRodd-NielsenEOrstedHSibbaldRG. The case for diabetic foot screening. Diabet Foot Can. 2013;1(2):8–14.
11.
AlahdabFWangATElraiyahTA. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3):42S–53S. doi:10.1016/j.jvs. Consulté le 8 décembre 2014.
BoothGPolskyJGozdyraP. Toronto, Canada: Institute for Clinical Evaluative Sciences (ICES); 2012.
14.
BradburyAWRuckleyCVFowkesFGR. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.
15.
BaerlocherMO. Canada’s slow adoption of new technologies adds burden to healthcare system. Can Med Assoc J. 2007; 176(5):616. doi:10.1503/cmaj.060727.
